Anthropic has introduced Claude Duet, a new AI assistant app designed to help professionals and small businesses automate and manage tasks. Unlike personal assistants, Claude Duet focuses on creating daily briefings, dashboards, and suggesting actions based on user data, rather than handling errands or bookings. It operates in the background, requiring user approval for sensitive actions like payments, but does not handle securities trading or money transfers. The app, built on the Claude Opus 5.5 model, supports over 6,000 connectors and plugins, and is available on iOS, Android, and web for Pro and Max users via a waitlist during its research preview phase.
The Claude Duet app by Anthropic is a new AI assistant designed for professionals and small businesses. For readers following the Technology sector, here is Pluang's market snapshot as of Oct 22, 2026 20:31 WIB: out of 150 priced US Technology stocks, 54 rose and 94 fell. Notable movers include LRCX at USD 235.83 with a -9.58% change and 97% buy order activity, NOK at USD 8.46 with an -8.64% change and nearly balanced order activity, and AXTI at USD 54.19 with an -8.59% change and 70% sell order activity.
Dayton T. Brown, Inc. inaugurated its new 104,000-square-foot Test & Qualification Center in Huntsville, Alabama, enhancing its capacity to support aerospace, defense, and propulsion programs. The facility's strategic location near Huntsville's aeros...
A new study by The Grossman Group reveals that while 60% of chief communications officers (CCOs) have influence at the leadership level, their communications functions lack the necessary systems, skills, and AI capabilities to fully meet their mandat...
More than 200 companies are actively developing over 240 Alzheimer's disease therapies, with around 20 drugs in late-stage trials and many others in earlier phases. Key players include Eli Lilly, Biogen, Johnson & Johnson, and Eisai, focusing on inno...
Sagimet Biosciences has initiated a crucial Phase 3 clinical trial in the U.S. for denifanstat, an oral treatment targeting moderate to severe acne. The trial, named AURORA, aims to enroll around 800 patients, including adolescents, to support regula...
Nokia reported third-quarter 2026 earnings per share of $0.10, surpassing the $0.08 estimate, and revenue of $5.78 billion, exceeding the $5.72 billion forecast. The company's AI and cloud sales surged 123%, driven by high demand for its IP Networks ...
